Exact Mass: 417.08216819999996
Exact Mass Matches: 417.08216819999996
Found 87 metabolites which its exact mass value is equals to given mass value 417.08216819999996,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
2-Deoxy-5-hydroxymethylcytidine-5-diphosphate
C10H17N3O11P2 (417.03383119999995)
Grixazone B
C18H15N3O7S (417.06306800000004)
A cysteine derivative that is the S-(2-amino-8-carboxy-3-oxo-3H-phenoxazin-1-yl) derivative of N-acetyl-L-cysteine.
Pelargonidin 3-rhamnoside
C21H21O9+ (417.11855160000005)
Pelargonidin 3-rhamnoside is found in fruits. Pelargonidin 3-rhamnoside is isolated from Ficus sp. and others. Isolated from Ficus species and others. Pelargonidin 3-rhamnoside is found in herbs and spices and fruits.
Ochratoxin A methyl ester
C21H20ClNO6 (417.0979090000001)
Pexidartinib
C20H15ClF3N5 (417.09680160000005)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
Temafloxacin
C21H18F3N3O3 (417.13001940000004)
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors
Triazolo-benzophenone
C19H17Cl2N5O2 (417.07592420000003)
Cc1cc(N=Nc2ccc(cc2)S(=O)(=O)Nc2ccccn2)c(N)c(Cl)c1O
C18H16ClN5O3S (417.06623360000003)
3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE
C19H13F2N3O2S2 (417.04172220000004)
2-hydroxy-7-(beta-D-glucopyranosyloxymethyl)-8,8-dimethyl-4,8-dihydrobenzo[1,4]thiazine-3,5-dione
2-[(3,4-Dihydro-1-oxo-3-methyl-5-chloro-8-hydroxy-1H-2-benzopyran-7-yl)carbonylamino]-3-phenylpropanoic acid methyl ester
C21H20ClNO6 (417.0979090000001)
Coptisine sulfate
C19H15NO8S (417.05183500000004)
Coptisine Sulfate is an alkaloid from Chinese goldthread, and acts as an efficient uncompetitive IDO inhibitor with a Ki value of 5.8 μM and an IC50 value of 6.3 μM[1]. Coptisine Sulfate is an alkaloid from Chinese goldthread, and acts as an efficient uncompetitive IDO inhibitor with a Ki value of 5.8 μM and an IC50 value of 6.3 μM[1].
dichlorodihydroxybis(isopropylamine)platinum
C6H20Cl2N2O2Pt (417.05496100000005)
N-(5-CHLOROBENZO[D][1,3]DIOXOL-4-YL)-7-FLUORO-5-((TETRAHYDRO-2H-PYRAN-4-YL)OXY)QUINAZOLIN-4-AMINE
C20H17ClFN3O4 (417.08915640000004)
Bisoxatin acetate
C24H19NO6 (417.12123140000006)
5,6-Dihydrobis[1,3]benzodioxolo[5,6-a:5,6-g]quinolizinium sulfate (1:1)
C19H15NO8S (417.05183500000004)
trimethyl-[[1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolo[2,3-b]pyridin-3-yl]methyl]azanium,iodide
Bretazenil
C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants
Sulfatolamide
G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids > G01AE - Sulfonamides C254 - Anti-Infective Agent > C2166 - Combination Anti-Infective Agent D000890 - Anti-Infective Agents > D013424 - Sulfanilamides
4-Methylumbelliferyl2-sulfamino-2-deoxy-a-D-gluc]
C16H19NO10S (417.07296340000005)
Tetraethylenepentamine polyisobutylene succinimide,molybdenum complex,sulfurized
C12H25MoN5O5------ (417.09096500000004)
3-[[4-[(6,7-dichlorobenzothiazol-2-yl)azo]-3-methylphenyl]ethylamino]propiononitrile
C19H17Cl2N5S (417.0581662000001)
nile blue perchlorate
C20H20ClN3O5 (417.1091420000001)
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D049408 - Luminescent Agents D004396 - Coloring Agents > D005456 - Fluorescent Dyes
3-[4-[(5,6-dichloro-1,3-benzothiazol-2-yl)diazenyl]-N-ethyl-3-methylanilino]propanenitrile
C19H17Cl2N5S (417.0581662000001)
2-(5-Methoxy-1H-indol-3-yl)-1-tosyl-1H-pyrrolo[2,3-b]pyridine
C23H19N3O3S (417.11470640000005)
4-[(2E)-2-(2-amino-3-chloro-5-methyl-4-oxocyclohexa-2,5-dien-1-ylidene)hydrazinyl]-N-pyridin-2-ylbenzenesulfonamide
C18H16ClN5O3S (417.06623360000003)
N-(3-Chloro-4-Methoxy-Phenyl)-N-(3,4,5-Trimethoxyphenyl)-1,3,5-Triazine-2,4-Diamine
C19H20ClN5O4 (417.1203750000001)
Pexidartinib
C20H15ClF3N5 (417.09680160000005)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
6-bromo-2-(4-methylphenyl)-N-(pyridin-3-yl)quinoline-4-carboxamide
6-[3-Hydroxy-2-(3,5,7-trioxononanoyl)phenyl]-3,5-dioxohexanoate
C21H21O9- (417.11855160000005)
kaempferol 3-O-beta-D-xyloside(1-)
C20H17O10- (417.08216819999996)
An organic anion obtained by selective deprotonation of the 7-hydroxy group of kaempferol 3-O-beta-D-xyloside; major species at pH 7.3.
1-O-[[2-(Sulfoamino)-2,4-dideoxy-D-glucopyranose]-4-yl]-4,5-didehydro-6-oxo-4-deoxy-beta-D-glucopyranose
(4aS,5S,12aS)-1,4a,5,8,10,11,12a-heptahydroxy-3,12-dioxo-4,5-dihydrotetracene-2-carboxamide
C19H15NO10 (417.06959300000005)
3-[2-(3,4-Dihydroxy-phenyl)-3,5-dihydroxy-4-oxo-4H-chromen-7-yloxymethyl]-benzonitrile
N-(2-phenylethyl)-5-thiophen-2-yl-7-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxamide
C19H14F3N5OS (417.08711100000005)
1-(4-ethoxyphenyl)-2-[6-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanylmethyl]-4-oxo-1H-pyrimidin-2-yl]guanidine
C17H19N7O2S2 (417.10415939999996)
Acetic acid [4-[acetyl-(4-chlorophenyl)sulfonylamino]-1-naphthalenyl] ester
C20H16ClNO5S (417.0437676000001)
N,N-diethyl-5-nitro-2-[(2-oxo-3-indolyl)hydrazo]benzenesulfonamide
N-(2-methyl-1,3-benzothiazol-6-yl)-4-(4-morpholinylsulfonyl)benzamide
3-(2-hydroxyphenyl)-N-{[5-(8-quinolinylthio)-2-furyl]methylene}propanohydrazide
C23H19N3O3S (417.11470640000005)
N-[(1S)-1-(1H-benzimidazol-2-yl)-3-(methylthio)propyl]-2-(4-chlorophenoxy)-2-methylpropanamide
C21H24ClN3O2S (417.12776740000004)
(3E)-3-(4-bromobenzylidene)-1-(2-hydroxyphenyl)-5-phenyl-1,3-dihydro-2H-pyrrol-2-one
2-(4-chlorophenoxy)-N-[3-(dimethylamino)propyl]-N-(4-methyl-1,3-benzothiazol-2-yl)acetamide
C21H24ClN3O2S (417.12776740000004)
4-(4-Morpholinyl)-3-nitrobenzoic acid 2-[3-(cyanomethyl)-4-methyl-5-thiazol-3-iumyl]ethyl ester
C19H21N4O5S+ (417.12325960000004)
N-[4-(4-chlorophenyl)-2-thiazolyl]-N-[3-(diethylamino)propyl]-2-furancarboxamide
C21H24ClN3O2S (417.12776740000004)
ammine(cyclohexylamine)dihydroxodichloroplatinum(IV)
C6H20Cl2N2O2Pt (417.05496100000005)
Trovafloxacin(1+)
An organic cation that is the conjugate acid of trovafloxacin, obtained by protonation of the primary amino group.
N(6)-acetyl-N(2)-(5-phosphonatopyridoxyl)-L-lysinate(2-)
3-[(5E)-5-[[3-[(4-fluorophenyl)methoxy]phenyl]methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]propanoic acid
[3-[(E)-(2-Amino-4-oxo-1,3-thiazol-5-ylidene)methyl]phenyl] 4-acetamidobenzenesulfonate
C18H15N3O5S2 (417.04531000000003)
temafloxacin
C21H18F3N3O3 (417.13001940000004)
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors
N(6)-acetyl-N(2)-(5-phosphonatopyridoxyl)-L-lysinate(2-)
Dianion of N(6)-acetyl-N(2)-(5-phosphopyridoxyl)-L-alanine having anionic carboxy, hydroxy and phosphate groups and the secondary amino group and pyridine nitrogen protonated.
2-deoxy-5-hydroxymethyl-CDP
C10H17N3O11P2 (417.03383119999995)
A pyrimidine 2-deoxyribonucleoside 5-diphosphate that is 2-deoxycytidine 5-diphosphate (CDP) substituted by a hydroxymethyl group at position 5.
2-[(3s,3ar)-7-chloro-3a-{[(2s,3s,5s,6r)-3,5-dihydroxy-5,6-dimethyl-4-oxooxan-2-yl]oxy}-3-hydroxy-3h-cyclopenta[a]inden-5-yl]acetonitrile
C21H20ClNO6 (417.0979090000001)
(2r)-2,3-dihydroxy-8,8-dimethyl-7-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-2h-1,4-benzothiazin-5-one
8-amino-9-({2-carboxy-2-[(1-hydroxyethylidene)amino]ethyl}sulfanyl)-7-oxophenoxazine-2-carboxylic acid
C18H15N3O7S (417.06306800000004)